Susan Lösler

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
During the last years remission rates of more than 72% for arsenic(III)-oxide (As2O3) treatment in relapsed or refractory acute promyelocytic leukemia have been published. As2O3 is under clinical(More)
  • 1